share_log

Why Hainan Haiyao's (SZSE:000566) Earnings Are Better Than They Seem

Why Hainan Haiyao's (SZSE:000566) Earnings Are Better Than They Seem

爲甚麼海南海藥(SZSE: 000566)的收益好於預期
Simply Wall St ·  2023/04/17 04:21

Hainan Haiyao Co., Ltd.'s (SZSE:000566) solid earnings announcement recently didn't do much to the stock price. Our analysis suggests that shareholders might be missing some positive underlying factors in the earnings report.

海南海藥股份有限公司's (SZSE: 000566) 最近公佈的穩健財報並沒有對股價產生太大影響。我們的分析表明,股東在收益報告中可能缺少一些積極的潛在因素。

Check out our latest analysis for Hainan Haiyao

看看我們對海南海藥的最新分析

earnings-and-revenue-history
SZSE:000566 Earnings and Revenue History April 17th 2023
深交所:000566 收益和收入歷史記錄 2023 年 4 月 17 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

For anyone who wants to understand Hainan Haiyao's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥15m due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Hainan Haiyao to produce a higher profit next year, all else being equal.

對於任何想了解海南海藥在法定數字之外的利潤的人來說,值得注意的是,在過去的十二個月中,由於不尋常的項目,法定利潤減少了1500萬元人民幣。儘管由於不尋常物品而產生的扣除額一開始令人失望,但有一線希望。我們調查了數千家上市公司,發現不尋常的物品本質上往往是一次性的。而且,畢竟,這正是會計術語所暗示的。因此,假設這些不尋常的支出不會再次出現,那麼在其他條件相同的情況下,我們預計海南海藥明年將產生更高的利潤。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Hainan Haiyao.

注意: 我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對海南海藥的資產負債表分析。

Our Take On Hainan Haiyao's Profit Performance

我們對海南海藥盈利表現的看法

Unusual items (expenses) detracted from Hainan Haiyao's earnings over the last year, but we might see an improvement next year. Because of this, we think Hainan Haiyao's earnings potential is at least as good as it seems, and maybe even better! And one can definitely find a positive in the fact that it made a profit this year, despite losing money last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Case in point: We've spotted 2 warning signs for Hainan Haiyao you should be mindful of and 1 of these makes us a bit uncomfortable.

不尋常的項目(支出)減少了海南海藥去年的收益,但明年我們可能會看到改善。正因爲如此,我們認爲海南海藥的盈利潛力至少和看起來一樣好,甚至可能更好!儘管去年虧損,但它今年還是實現了盈利,這一事實絕對可以從中找到積極的一面。當然,在分析其收益時,我們只是浮出水面;人們也可以考慮利潤率、預測增長和投資回報率等因素。有鑑於此,如果你想對公司進行更多分析,瞭解所涉及的風險至關重要。一個很好的例子:我們發現了 海南海藥有 2 個警告信號 你應該注意,其中之一讓我們有點不舒服。

This note has only looked at a single factor that sheds light on the nature of Hainan Haiyao's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

這份報告只着眼於一個揭示海南海藥利潤性質的單一因素。但是,還有很多其他方法可以告知你對公司的看法。有些人認爲高股本回報率是業務質量的好兆頭。雖然可能需要代表你做一些研究,但你可能會發現這一點 免費的 一系列擁有高股本回報率的公司,或者這份內部人士爲了有用而買入的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂? 取得聯繫 直接和我們聯繫。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St 的這篇文章本質上是一般性的。 我們僅使用不偏不倚的方法根據歷史數據和分析師預測提供評論,我們的文章並非旨在提供財務建議。 它不構成買入或賣出任何股票的建議,也沒有考慮您的目標或財務狀況。我們的目標是爲您提供由基本面數據驅動的長期重點分析。請注意,我們的分析可能未將最新的價格敏感型公司公告或定性材料考慮在內。簡而言之,華爾街對上述任何股票都沒有頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論